Compounds that inhibit bacterial virulence factors from the mono-ADP-ribosyltransferase (mART) family of toxins have been identified that are not toxic to cells or the producing bacterial pathogen. These compounds have great potential as antivirulence agents for treating many bacterial infections and disease states.
PAPD5 INHIBITORS AND METHODS OF USE THEREOF
申请人:Children`s Medical Center Corporation
公开号:US20210177827A1
公开(公告)日:2021-06-17
The disclosure relates to compounds that are, e.g., PAP Associated Domain Containing 5 (PAPD5) inhibitors and methods of use thereof.